amorphous pharmaceutical materials
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
July 27 by Pharma IQThe use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable drug properties and the latest findings from Pharma IQ suggest that many developers consider...
The Rise of Academic/Industry Collaboration in Amorphous Material Studies
May 30 by Helen WinsorMarc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the u...
Implementing Thermal Processing Technologies for the Production of Amorphous Solid Dispersions
September 05 by Helen WinsorAmorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid state development. Dr. Dave Miller, Senior Principal Scientist at Hoffmann-La Roche, speaks to...
Amorphous Material Studies: Collaboration, Commitment and Compliance
April 27 by Marc DescampsMarc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Pharma IQ to discuss the use of amorphous pha...